Abstract:Journal of DiabetesVolume 4, Issue 4 p. 359-361 CASE REPORT Remission induced by autologous hematopoietic stem cell transplantation in one newly diagnosed type 1 diabetes patient with diabetic ketoacidosis: A case report Shanmei Shen, Shanmei Shen Divisions of EndocrinologySearch for more papers by this authorLirong Li, Lirong Li Divisions of EndocrinologySearch for more papers by this authorJian Ouyang, Jian Ouyang Hematology, The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, ChinaSearch for more papers by this authorJingyan Xu, Jingyan Xu Hematology, The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, ChinaSearch for more papers by this authorDalong Zhu, Dalong Zhu Divisions of EndocrinologySearch for more papers by this author Shanmei Shen, Shanmei Shen Divisions of EndocrinologySearch for more papers by this authorLirong Li, Lirong Li Divisions of EndocrinologySearch for more papers by this authorJian Ouyang, Jian Ouyang Hematology, The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, ChinaSearch for more papers by this authorJingyan Xu, Jingyan Xu Hematology, The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, ChinaSearch for more papers by this authorDalong Zhu, Dalong Zhu Divisions of EndocrinologySearch for more papers by this author First published: 14 June 2012 https://doi.org/10.1111/j.1753-0407.2012.00214.xCitations: 8 Dalong Zhu, Division of Endocrinology, Affiliated Drum Tower Hospital of Nanjing University, 321 Zhongshan Road, Nanjing 210008, China. Tel: +86 25 83 105302 Fax: +86 25 83 105313 Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1LoCascio SA, Spinelli J, Kurtz J. Hematopoietic stem cell transplantation for the treatment of autoimmunity in type 1 diabetes. Curr Stem Cell Res Ther. 2011; 6: 29–37. 2Milanetti F, Abinun M, Voltarelli JC, Burt RK. Autologous hematopoietic stem cell transplantation for childhood autoimmune disease. Pediatr Clin N Am. 2010; 57: 239–71. 3Sia C, Homo-Delarche F. Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes. Rev Diabet Stud. 2004; 1: 198–206. 4Hasegawa Y, Ogihara T, Yamada T et al.Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology. 2007; 148: 2006–15. 5Ablamunits V, Sherry NA, Kushner JA et al.Autoimmunity and beta cell reneneration in mouse and human type 1 diabetes: The peace is not enough. Ann N Y Acad Sci. 2007; 1103: 19–32. 6Steffes MW, Sibley S, Jackson M et al.Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care. 2003; 26: 832–6. 7 The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. Ann Intern Med. 1998; 128: 517–23. 8Voharelli JC, Couri EB, Boris N et al.Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type l diabetes mellitus. JAMA. 2007; 297: 1568–77. 9Couri CE, Oliveira MC, Stracieri AB et al.C-Peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009; 301: 1573–9. 10Asano M, Toda M, Sakaguchi N et al.Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996; 184: 387–96. 11Roord ST, de Jager W, Boon L et al.Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood. 2008; 111: 5233–41. Citing Literature Volume4, Issue4December 2012Pages 359-361 ReferencesRelatedInformation

Autoimmune Diabetes Is Suppressed by Treatment with Recombinant Human Tissue Kallikrein-1

Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice.

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab′)2 Antibody Treatment through Secreting Transforming Growth Factor-β

Interleukin-1 Receptor Antagonist Improves Normoglycemia and Insulin Sensitivity in Diabetic Goto-Kakizaki-Rats

Beyond Knockout: A Novel Homodimerization-Targeting MyD88 Inhibitor Prevents and Cures Type 1 Diabetes in NOD Mice

Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes

Latent TGF-β1 Protects Against Diabetic Kidney Disease Via Arkadia/Smad7 Signaling

Exogenous Kallikrein Protects Against Diabetic Nephropathy.

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function

Beta cells deficient for Renalase counteract autoimmunity by shaping natural killer cell activity

387-P: Novel Mitochondrial Complex I Modulator Reduces Diabetes-Associated Expression of Inflammation and Fibrosis Markers in Human Proximal Tubular Epithelial Cells

Systemic Klotho therapy protects against insulitis and enhances beta-cell mass in NOD mice

Human Tissue Kallikrein 1 Improves Erectile Dysfunction of Streptozotocin-Induced Diabetic Rats by Inhibition of Excessive Oxidative Stress and Activation of the PI3K/AKT/eNOS Pathway

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

Orally delivered all-trans-retinoic acid- and transforming growth factor-β-loaded microparticles ameliorate type 1 diabetes in mice

Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice

Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

Remission Induced by Autologous Hematopoietic Stem Cell Transplantation in One Newly Diagnosed Type 1 Diabetes Patient with Diabetic Ketoacidosis: a Case Report.